Form D · Other Health Care
ATED Therapeutics Ltd.
Greenwich, CT · CIK 0002114239
Offering snapshot reported Apr 2, 2026 · SEC filing
- Reported sold
- $670K Offering amount: $670K
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 24, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 2, 2026 | Initial | $670,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-578816
Source: Form D, filed Apr 2, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Chiarelli | Director, Executive |
| Jeff R. Swarz | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
One Sound Shore Drive Suite 103
Greenwich, CT, 06830
Greenwich, CT, 06830